Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial.
Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders.
Human Aquaporin-4 and Molecular Modeling: Historical Perspective and View to the Future.
Stereotactic injection of shrna GSK-3β-AAV promotes axonal regeneration after spinal cord injury.
ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis.
The immunogenetics of multiple sclerosis. The frequency of HLA-alleles class 1 and 2 is lower in Southern Brazil than in the European population.
Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Hormone replacement in menopausal women with multiple sclerosis: Looking back, thinking forward.
Oxidative damage and chemokine production dominate days before immune cell infiltration and EAE disease debut.
Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matter.
Specific MRI findings help distinguish acute transverse myelitis of Neuromyelitis Optica from spinal cord infarction.
MicroRNA 182 inhibits CD4(+)CD25(+)Foxp3(+) Treg differentiation in experimental autoimmune encephalomyelitis.
Neuromuscular Diseases.
Astrocyte Dysfunction in Developmental Neurometabolic Diseases.
Pathophysiology, assessment and management of multiple sclerosis fatigue: an update.
Severe leukoencephalopathy with cortical involvement and peripheral neuropathy due to FOLR1 deficiency.
Blockade of glutamine synthetase enhances inflammatory response in microglial cells.
A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors.
Oxidative damage to myelin proteins accompanies peripheral nerve motor dysfunction in aging C57BL/6 male mice.
Utility of a Multiparametric Quantitative MRI Model That Assesses Myelin and Edema for Evaluating Plaques, Periplaque White Matter, and Normal-Appearing White Matter in Patients with Multiple Sclerosis: A Feasibility Study.
Myelin and oligodendrocyte lineage cells in white matter pathology and plasticity after traumatic brain injury.
Ontogeny of Tissue-Resident Macrophages.
The Importance of Thrombin in Cerebral Injury and Disease.
Euflammation attenuates peripheral inflammation-induced neuroinflammation and mitigates immune-to-brain signaling.
Protein tyrosine phosphatase SHP-1: resurgence as new drug target for human autoimmune disorders.
Pages
« first
‹ previous
…
837
838
839
840
841
842
843
844
845
…
next ›
last »